Search Results 1271-1280 of 18399 for Measles

  1. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis who require parenteral iron infusions or blood ...

  2. Mayo Clinic

    Share · Tweet . IMG-20077546. Home; espanol-historiasmayo-8coljpg. Fuel groundbreaking medical research! Give Today. Your donation powers the future of ...

  3. Ciltacabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Rubella Virus Vaccine, Live; Smallpox Monkeypox Vaccine; Typhoid Vaccine; Varicella Virus Vaccine, Live ...

  4. Felicity T. Enders, Ph.D. - Mayo Clinic Faculty Profiles

    Felicity T. Enders, Ph.D., a leading biostatistician at Mayo Clinic, advances research education, population health and workforce development.

  5. A Clinical Study To Investigate The Efficacy And Safety Of An Investigational Combination Therapy With BNT324 And BNT327 In Patients With Advanced Lung Cancer - Mayo Clinic

    The purpose of this study is to determine the RP2D of BNT324 in combination with BNT327 by assessing the safety and tolerability in participants with advanced ...

  6. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial - Mayo Clinic

    About this study. Is the treatment strategy of percutaneous left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) superior ...

  7. Mayo Clinic

    3X challenge extended through 1/15! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & ...

  8. Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML - Mayo Clinic

    About this study. To determine if the addition of midostaurin (PKC412) to Standard of Care (SOC) therapy reduces relapse in FLT3-ITD mutated AML patients ...

  9. Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals With Advanced Cancer - Mayo Clinic

    This study examines Stress Management and Resilience Training (SMART) for family caregivers (FCG) of patients receiving chemotherapy for advanced cancer to ...